Immunoglobulin A (IgA) nephropathy results from the accumulation of IgA-containing immune complexes (IgA-ICs) and aberrant ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...

Skin, our largest organ, acts as a protective barrier against pathogens that try to invade our bodies while constantly monitoring for potential threats. In the skin's outermost layer, the epidermis, ...

FREDERICK, Md., Feb. 18, 2026 /PRNewswire/ -- Do you know why passenger and freight planes are not using renewable biofuel? It's a simple reason - it costs too much. "Converting stems and leaves from ...

– Initiation of RLYB116 Phase 2 Clinical Trial in Immune Platelet Transfusion Refractoriness Currently Planned for 2H 2026 with Potential for Topline Data in 2027 – NEW HAVEN, Conn.--(BUSINESS ...

A study published in Nature Medicine identified a link between the placebo effect and immune system function. In the experiment, individuals who generated positive expectations showed a stronger ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may outperform existing treatments from Apellis Pharmaceuticals and Astellas ...

Cedars-Sinai investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease. Science X ...

The state of Alaska is considering opening up a new ferry terminal in Southeast Alaska, connecting Alaska’s ferries to the Lower 48 road system without going through Canada. The idea comes as Alaska ...

DETROIT – Detroit’s public transit system is poised for significant upgrades this spring with the opening of a new state-of-the-art DDOT Coolidge Terminal and a $50 million federal grant to replace ...